These CPT-11 prodrugs appear to accumulate in brain tumors, have long intra-tumoral half-lives, and slowly release their CPT-11 cargo within the tumor to be converted to the potent TOP1 inhibitor, SN-38. This evidence concerns the gene TOP1 and neoplasm.